MedTrace Logo

Eye Recovery Automation for Post Injury Dysfunction (iRAPID)

NCT06105892 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-04-14

No results posted yet for this study

Summary

This study will test a portable virtual reality (VR) system with integrated eye tracking called Virtual Eye Rotation Vision Exercises (VERVE). The proposed VERVE platform will deliver vergence therapy in an automated manner. This research will involve 30 non-traumatic brain injury (TBI) binocularly normal (BNC) Veterans and 50 post-traumatic convergence insufficiency (PTCI) Veterans who will undergo Active and Sham therapy (equally divided groups) to determine the effectiveness of VERVE vergence therapy.

Conditions

Interventions

DEVICE

Virtual Eye Rotation Vision Exercise (VERVE)

VERVE utilizes a virtual reality (VR) headset with integrated eye-tracking where the patient makes specific vergence eye movements by playing a VR game controlled by eye movements. Participants will be making convergence and divergence eye movements as steps and ramps.

DEVICE

Sham VR Therapy

VERVE game without changes in eye movement demands. Maximizing gameplay with no intervention.

Sponsors & Collaborators

  • U.S. Army Medical Research and Development Command

    collaborator FED

  • University of New Mexico

    collaborator OTHER

  • Biomedical Research Institute of New Mexico

    collaborator OTHER

  • New Mexico VA Healthcare System

    collaborator FED

  • New Jersey Institute of Technology

    lead OTHER

Principal Investigators

  • Chang Yaramothu, PhD · New Jersey Institute of Technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-23
Primary Completion
2027-06-20
Completion
2027-09-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06105892 on ClinicalTrials.gov